Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalworth Regulatory News (GWI)

Share Price Information for Globalworth (GWI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.46
Bid: 2.36
Ask: 2.46
Change: 0.00 (0.00%)
Spread: 0.10 (4.237%)
Open: 2.46
High: 2.46
Low: 2.46
Prev. Close: 2.41
GWI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Offer Update and Advice to Shareholders

12 Jul 2021 14:49

RNS Number : 9680E
Globalworth Real Estate Inv Ltd
12 July 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

12 July 2021

Globalworth Real Estate Investments Limited ("Globalworth" or the "Company")

Offer Update and Advice to Shareholders

 

On 14 April 2021, CPI Property Group S.A. ("CPI") and Aroundtown SA ("Aroundtown" and, together with CPI, the "Consortium") announced a unilateral cash offer for the Company (the "Offer"). On 26 April 2021, a committee of independent directors of the Company (the "Independent Committee") advised shareholders that the Offer significantly undervalued the Company and recommended that shareholders not accept the offer.

 

On 5 July 2021, CPI and Aroundtown notified Globalworth that their holdings in the Company had been combined (the "Consolidation"), resulting in Zakiono Enterprises Limited ("Zakiono", an entity indirectly owned by the Consortium) holding 51.50% of the shares in the Company. As a result, Zakiono held sufficient voting rights to exert statutory control over the Company, including in due course the ability to appoint and remove directors from the board, without the need to maintain a majority of independent directors.

 

On 8 July 2021, the Consortium announced that the final anti-trust condition to the Offer had been satisfied. The Consortium later announced that it owned or had received valid acceptances to the Offer in respect of 54.08 per cent. of the issued share capital of Globalworth and that it had reduced the percentage required to satisfy the Acceptance Condition to more than 50 per cent. of the voting rights then normally exercisable at a general meeting of Globalworth.

 

Accordingly, the Consortium declared the Offer unconditional in all respects and that the Offer is to close on 23 July 2021.

 

Copies of certain announcements and documents relating to the Offer may be viewed on the Globalworth website at https://www.globalworth.com/investor-relations/offer-for-globalworth/.

 

INDEPENDENT COMMITTEE'S FURTHER VIEWS IN RELATION TO THE OFFER

 

The Independent Committee continues to believe that the Offer significantly undervalues the Company, its assets and its prospects.

 

As set out in the response circular on 26 May 2021 (the "Response Circular"), the Independent Committee notes that the Consortium's limited disclosure provides that it:

· does not currently intend to make any changes to existing employment rights, including pension rights, of the management and employees of Globalworth and its subsidiaries;

· does not currently intend to change the places of Globalworth's business, including the location of its headquarters and the headquarters' functions;

· does not intend to redeploy any of Globalworth's fixed assets; and

· intends to maintain Globalworth's AIM admission.

 

The Independent Committee notes that the Consortium's intention to maintain Globalworth's AIM admission applies until 8 July 2022 but also notes that, if the Consortium deviates from this statement of intention during this period, they will be required to make an announcement in accordance with Rule 19.6(b) of the City Code on Takeovers and Mergers. In any event (whether before or after 8 July 2022), any proposed cancellation of Globalworth's AIM admission at the request of the Company would be conditional upon the consent of not less than 75% of votes cast by Globalworth Shareholders at a general meeting. In addition, Globalworth's AIM admission could be cancelled if required by the AIM Rules.

 

The Consortium has also stated an intention, following the Offer becoming or being declared unconditional in all respects, to:

· within six months of the Offer completing, undertake a strategic review of Globalworth's business;

· make changes to the Globalworth Board in order to reflect the Consortium's majority shareholding in Globalworth, with the effect that the Consortium intends to take control of the Globalworth Board and cause Globalworth to implement the Consortium's (unstated) strategy going forward; and

· consider proposals regarding the incentivisation of management and employees that may include arrangements to secure the ongoing participation of Globalworth's senior management.

 

As a result of the Consolidation, and the Offer having been declared unconditional in all respects, the Independent Committee now expects these actions to be taken. Furthermore, the Independent Committee notes the following:

· the Consortium is now able to exercise statutory control over the Company and pass ordinary resolutions. As a result there is a material risk that the Consortium may now seek to weaken or remove current governance protections that benefit Globalworth's minority shareholders;

· by virtue of Zakiono acquiring statutory control over the Company, the requirement in the Company's Articles for the Globalworth Board to maintain a majority of independent directors no longer applies;

· the Consortium has provided no description of its anticipated plans for Globalworth or the basis for its assertion that those plans will improve Globalworth's business performance;

· a combination of weakened governance protections and the Consortium's anticipated plans for Globalworth could, among other things, result in Globalworth generating reduced profits available for the purpose of paying dividends, reducing income for shareholders and depressing the value of the Globalworth Shares;

· there is a material risk that reduced liquidity of the Globalworth Shares would severely impact their trading value;

· although the Consortium may not, without the consent of the Takeover Panel, make another offer, or acquire any further Globalworth Shares on more favourable terms to those made available under the Offer (or provide additional consideration for Globalworth Shares acquired pursuant to the Offer) within six months of closure of the Offer, the Consortium will generally be able to acquire Globalworth Shares in the market, further consolidating its position of control; and

· the Consortium may de-consolidate its ownership of the Company, which, depending on the number of Globalworth Shares held by Zakiono at the time, may mean that each of CPI and Aroundtown would individually be able to exert control of the Company.

 

The Independent Committee notes that the Consortium has ignored all offers by the Independent Committee to engage and explore avenues that may result in delivering greater value to all Globalworth Shareholders.

 

The Independent Committee, which has been so advised by J.P. Morgan and Panmure Gordon as to the financial terms of the Offer, continues to believe that the Offer significantly undervalues Globalworth, its assets and its prospects. In providing its financial advice to the Independent Committee, each of J.P. Morgan and Panmure Gordon has taken into account the commercial assessment of the Independent Committee. Panmure Gordon is providing independent financial advice to the Independent Committee for the purposes of Rule 3 of the Code.

 

However, the Independent Committee advises Globalworth Shareholders to consider the factors set out above in making a decision as to whether to accept the Offer. In particular, Globalworth Shareholders should weigh, in light of their individual circumstances, the significant undervaluation that the Offer terms represent against the detrimental impact the Consolidation and further increases in the Consortium's shareholding, whether pursuant to the Offer or subsequently, may have on governance, liquidity and the price at which Globalworth Shares trade.

 

The members of the Independent Committee who hold Globalworth Shares, having considered their own positions in light of the above factors, intend to accept the Offer in respect of all or part of their own interests in Globalworth Shares.

 

Whilst the Globalworth CEO believes that the Offer Price does not reflect the fundamental value of the Company, in light of his personal circumstances and concern as to the future liquidity and trading value of the Globalworth Shares, the Globalworth CEO intends to accept the Offer.

 

Globalworth Shareholders should be aware that Zakiono is able to acquire further Globalworth Shares in the market without being required to make any further offer, which would both consolidate its control of the Company and reduce the liquidity of Globalworth Shares.

 

Terms used but not defined in this announcement shall have the meanings given to them in the Response Circular.

 

Enquiries:

 

Globalworth

Via advisers

Geoff Miller, Chair of the Board

J.P. Morgan Cazenove (Financial Adviser)

Tel: +44 20 7742 4000

Massimo Saletti / Leon Li

Dwayne Lysaght / Jonty Edwards

Panmure Gordon (Rule 3 Adviser, Nominated Adviser and Joint Broker)

Tel: +44 20 7886 2500

Dominic Morley / Alina Vaskina

 

Important notices

This announcement is not intended to and does not constitute an offer to buy or the solicitation of an offer to subscribe for or sell or an invitation to purchase or subscribe for any securities or the solicitation of any vote in any jurisdiction. The release, publication or distribution of this announcement in whole or in part in, into or from certain jurisdictions may be restricted by law and therefore persons in such jurisdictions should inform themselves about and observe such restrictions.

The person responsible for arranging for the release of this announcement on behalf of the Company is Nicola Marrin, Company Secretary.

Disclaimers

J.P. Morgan Securities plc, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), is authorised in the United Kingdom by the Prudential Regulation Authority (the "PRA") and regulated in the United Kingdom by the PRA and the Financial Conduct Authority. J.P. Morgan Cazenove is acting as financial adviser exclusively for Globalworth and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than Globalworth for providing the protections afforded to clients of J.P. Morgan Cazenove or its affiliates, nor for providing advice in relation to any matter referred to herein.

Panmure Gordon (UK) Limited ("Panmure Gordon") which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively for Globalworth and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this document and will not be responsible to anyone other than Globalworth for providing the protections afforded to clients of Panmure Gordon or its affiliates, nor for providing advice in relation to any matter referred to herein.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OUPEADXAFLSFEFA
Date   Source Headline
26th Apr 20247:00 amRNSExchange Offer Final Settlement
22nd Apr 20244:35 pmRNSExchange Offer Final Results
11th Apr 20243:03 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
10th Apr 202411:49 amRNSExchange Offer Early Exchange Deadline Results
3rd Apr 20247:00 amRNSSatisfaction of employee share awards and TVR
28th Mar 20244:25 pmRNSExchange Offer for Outstanding Notes 2025 and 2026
28th Mar 202412:00 pmRNSCorrection - Scrip Dividend Share Reference Price
28th Mar 20247:00 amRNSScrip Dividend Share Reference Price
26th Mar 20249:41 amRNSBuy back of Shares into Treasury and TVR
22nd Mar 20244:06 pmRNSPublication of Annual Report and Date of AGM
12th Mar 20244:04 pmRNSInterim Dividend & Scrip Alternative
11th Mar 20243:48 pmRNSTransfer of shares out of treasury
11th Mar 20243:35 pmRNSPreliminary results FY23
11th Mar 20243:03 pmRNSSale of part of logistics portfolio
24th Nov 202312:34 pmRNSS&P - 'BB+' Rating affirmed
27th Sep 20237:00 amRNSIssue of Scrip Dividend Shares & Admission to AIM
19th Sep 20237:00 amRNSHalf-year Report
14th Sep 20237:00 amRNSScrip Dividend Share Reference Price
30th Aug 20237:00 amRNSInterim Dividend & Scrip Alternative
29th Aug 20233:43 pmRNSNotice of Interim Results & Prelim Interim Results
4th Jul 20237:00 amRNSInvestment grade rating maintained - Correction
3rd Jul 20236:19 pmRNSFitch investment grade credit rating maintained
27th Jun 20232:25 pmRNSResults of Tender Offers
20th Jun 20239:22 amRNSTender Offers Launch for 2025 Notes & 2026 Notes
19th Jun 202310:55 amRNSResult of AGM
8th Jun 20239:27 amRNSMoody's Ratings Action and Withdrawal
17th May 20237:00 amRNSAGM Notice & Availability of Annual Report
14th Apr 20233:52 pmRNSDirectorate Change
4th Apr 202312:33 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
31st Mar 20231:29 pmRNSBuy back of Shares into Treasury & TVR
24th Mar 20237:00 amRNSPosting of Annual Report and Date of AGM
23rd Mar 20237:00 amRNSScrip Dividend Share Reference Price
22nd Mar 20234:53 pmRNSS&P Rating Action
9th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20233:10 pmRNSInterim Dividend & Scrip Alternative
8th Mar 202312:12 pmRNSTransfer of Shares out of Treasury
8th Mar 202311:59 amRNSResult of EGM
3rd Mar 20237:00 amRNSCondensed Unaudited Results for FY 31 Dec 2022
24th Feb 20234:44 pmRNSNotice of EGM
23rd Dec 202210:30 amRNSNew Financing Facilities with the Erste Group
19th Dec 20227:00 amRNSCarbon Emissions Reduction Commitment
21st Oct 20223:00 pmRNSCEO succession
20th Sep 20227:00 amRNSHalf-year Report
16th Sep 20224:41 pmRNSSecond Price Monitoring Extn
16th Sep 20224:37 pmRNSPrice Monitoring Extension
31st Aug 20227:01 amRNSInterim Dividend Payment
31st Aug 20227:00 amRNSNotice of Interim Results & Prelim Interim Info
8th Jul 20227:00 amRNSStatement re stated post-offer intentions
21st Jun 202212:15 pmRNSRepayment of Bond
20th Jun 202210:36 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.